Glaucoma is a set of eye illnesses that damage the optic nerve, a nerve in the back of the eye that can cause vision loss and blindness. It is characterised by the death of retinal ganglion cells in the eye over time, culminating in irreversible vision loss. We now have powerful medicines that can drastically reduce the progression of glaucoma by lowering ocular pressure, thanks to research. Glaucoma is the primary cause of permanent blindness globally, owing to the fact that many people do not notice symptoms until the disease has progressed. Furthermore, even when very low ocular pressure is reached, some persons with severe glaucoma continue to decline. This is why it's critical to do research to better our scientific understanding of the condition and discover novel remedies.

•    Risk Factors
•    Marijuana and glaucoma
•    Causes and Symptoms
•    Diagnosis
•    Treatment

Market Analysis:
The glaucoma market is expected to grow from $2.85B in 2020 to $3.48B in 2030, a CAGR of 2%. The US is the biggest market of the 7MM, accounting for 75.0% market share in 2020. This is set to increase to 80.2% by 2030.